![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Research Insight
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective study
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective study including more than 260,000 patients that showed the risk...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read